UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Development of BACE1 inhibitors for Alzheimer's disease

Current medicinal chemistry, 2006-01, Vol.13 (15), p.1811

2006

Link zum Volltext

Verfügbarkeit prüfen

IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles

Bioorganic & medicinal chemistry letters, 2014-02, Vol.24 (4), p.1085-1088

2014

Link zum Volltext

Verfügbarkeit prüfen

Deriving Knowledge through Data Mining High-Throughput Screening Data

Journal of medicinal chemistry, 2004-12, Vol.47 (25), p.6373-6383

2004

Link zum Volltext

Verfügbarkeit prüfen

Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation

Journal of computer-aided molecular design, 2007-07, Vol.21 (7), p.379-393

2007

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as γ-secretase inhibitors

Bioorganic & medicinal chemistry letters, 2007-06, Vol.17 (11), p.3010-3013

2007

Link zum Volltext

Verfügbarkeit prüfen

III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl–piperazinyl–piperidine scaffold

Bioorganic & medicinal chemistry letters, 2011-12, Vol.21 (23), p.6982-6986

2011

Link zum Volltext

Verfügbarkeit prüfen

II. SAR studies of pyridyl–piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists

Bioorganic & medicinal chemistry letters, 2011-03, Vol.21 (5), p.1527-1531

2011

Link zum Volltext

Verfügbarkeit prüfen

Novel CXCR3 antagonists with a piperazinyl-piperidine core

Bioorganic & medicinal chemistry letters, 2009-09, Vol.19 (17), p.5205-5208

2009

Link zum Volltext

Verfügbarkeit prüfen

Privileged structure-based combinatorial libraries targeting G protein-coupled receptors

Assay and drug development technologies, 2003-08, Vol.1 (4), p.579-592

2003

Link zum Volltext

Verfügbarkeit prüfen

Orally active, nonpeptide oxytocin antagonists

Journal of medicinal chemistry, 1992-10, Vol.35 (21), p.3919-3927

1992

Link zum Volltext

Verfügbarkeit prüfen

Discovery and SAR of 4-amino-2-biarylbutylurea MCH 1 receptor antagonists through solid-phase parallel synthesis

Bioorganic & medicinal chemistry letters, 2005-08, Vol.15 (16), p.3691-3695

2005

Link zum Volltext

Verfügbarkeit prüfen

Discovery of tetralin ureas as potent melanin concentrating hormone 1 receptor antagonists

Bioorganic & medicinal chemistry letters, 2007-03, Vol.17 (6), p.1718-1721

2007

Link zum Volltext

Verfügbarkeit prüfen

Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis

Bioorganic & medicinal chemistry letters, 2005-08, Vol.15 (16), p.3696-3700

2005

Link zum Volltext

Verfügbarkeit prüfen

Preparation of encoded combinatorial libraries for drug discovery

Methods in molecular biology (Clifton, N.J.), 2002, Vol.201, p.23

2002

Link zum Volltext

Verfügbarkeit prüfen

Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines

Journal of medicinal chemistry, 1998-06, Vol.41 (12), p.2146-2163

1998

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of diphenyl thioether derivatives of peptides and aminoacids

Tetrahedron letters, 1987, Vol.28 (25), p.2805-2808

1987

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and anti-herpes virus activity of acyclic 2'-deoxyguanosine analogs related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine

Journal of medicinal chemistry, 1986-08, Vol.29 (8), p.1384-1389

1986

Link zum Volltext

Verfügbarkeit prüfen

Discovery and SAR of 4-amino-2-biarylbutylurea MCH 1 receptor antagonists through solid-phase parallel synthesis: G-protein-coupled receptors in drug discovery

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (16), p.3691-3695

2005

Link zum Volltext

Verfügbarkeit prüfen

LIBRARY DESIGN CONCEPTS AND IMPLEMENTATION STRATEGIES1

Journal of receptors and signal transduction, 2001, Vol.21 (4), p.311-356

2001

Link zum Volltext

Verfügbarkeit prüfen

Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis: G-protein-coupled receptors in drug discovery

Bioorganic & medicinal chemistry letters, 2005, Vol.15 (16), p.3696-3700

2005

Link zum Volltext

Verfügbarkeit prüfen

LIBRARY DESIGN CONCEPTS AND IMPLEMENTATION STRATEGIES

Journal of receptors and signal transduction, 2001-11, Vol.21 (4), p.311-356

2001

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of a Thioether Analog of the Macrocyclic Tripeptide K-13

Tetrahedron letters, 1989, Vol.30 (40), p.5405-5408

1989

Link zum Volltext

Verfügbarkeit prüfen

Non-peptide oxytocin antagonists: identification and synthesis of a potent camphor aminosuccinimide

Bioorganic & medicinal chemistry letters, 1995, Vol.5 (2), p.119-122

1995

Link zum Volltext

Verfügbarkeit prüfen

Nanomolar-affinity, non-peptide oxytocin receptor antagonists

Journal of medicinal chemistry, 1993-12, Vol.36 (25), p.3993-4005

1993

Link zum Volltext

Verfügbarkeit prüfen

MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1

Brain (London, England : 1878), 2019-07, Vol.142 (7), p.1876-1886

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of BACE1 inhibitors for Alzheimer's disease

IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles

Deriving Knowledge through Data Mining High-Throughput Screening Data

Understanding hERG inhibition with QSAR models based on a one-dimensional molecular representation

Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as γ-secretase inhibitors

III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl–piperazinyl–piperidine scaffold

II. SAR studies of pyridyl–piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists

Novel CXCR3 antagonists with a piperazinyl-piperidine core

Privileged structure-based combinatorial libraries targeting G protein-coupled receptors

Orally active, nonpeptide oxytocin antagonists

Discovery and SAR of 4-amino-2-biarylbutylurea MCH 1 receptor antagonists through solid-phase parallel synthesis

Discovery of tetralin ureas as potent melanin concentrating hormone 1 receptor antagonists

Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis

Preparation of encoded combinatorial libraries for drug discovery

Development of Orally Active Oxytocin Antagonists: Studies on 1-(1-{4-[1-(2-Methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl}piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and Related Pyridines

Synthesis of diphenyl thioether derivatives of peptides and aminoacids

Synthesis and anti-herpes virus activity of acyclic 2'-deoxyguanosine analogs related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine

Discovery and SAR of 4-amino-2-biarylbutylurea MCH 1 receptor antagonists through solid-phase parallel synthesis: G-protein-coupled receptors in drug discovery

LIBRARY DESIGN CONCEPTS AND IMPLEMENTATION STRATEGIES1

Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis: G-protein-coupled receptors in drug discovery

LIBRARY DESIGN CONCEPTS AND IMPLEMENTATION STRATEGIES

Synthesis of a Thioether Analog of the Macrocyclic Tripeptide K-13

Non-peptide oxytocin antagonists: identification and synthesis of a potent camphor aminosuccinimide

Nanomolar-affinity, non-peptide oxytocin receptor antagonists

MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1

Suchergebnisse filtern